Option Care Health (OPCH)
(Delayed Data from NSDQ)
$29.61 USD
+0.32 (1.09%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $29.61 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.61 USD
+0.32 (1.09%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $29.61 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth A Momentum B VGM
Zacks News
Option Care (OPCH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Investors Undervaluing Option Care Health (OPCH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Option Care (OPCH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Option Care (OPCH) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 10.34% and 2.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
4 Stocks to Watch in a Resilient Outpatient Home Health Industry
by Debanjana Dey
The rising dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
These 4 Stocks Boast Impressive Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. LRN, MOD, AMZN and OPCH are in a strong enough position to meet financial obligations.
Pick These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOH, ATO, AMZN and OPCH are sound enough to meet financial obligations.
Zacks Industry Outlook Highlights DaVita, Option Care Health, Addus HomeCare and Pennant
by Zacks Equity Research
DaVita, Option Care Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.
4 Stocks to Watch in an Evolving Outpatient Home Health Industry
by Debanjana Dey
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, OPCH, ADUS and PNTG are well-poised to gain.
Option Care (OPCH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 6.90% and 0.07%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.37% and 1.66%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Option Care Health (OPCH) in Q3 Earnings?
by Zacks Equity Research
Option Care Health's (OPCH) Q3 results are likely to be driven by sustained strong utilization.
OPCH or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
OPCH vs. CHE: Which Stock Is the Better Value Option?
Zacks.com featured highlights Arcos Dorados Holdings, Karat Packaging, The Andersons and Option Care Health
by Zacks Equity Research
Arcos Dorados Holdings, Karat Packaging, The Andersons and Option Care Health have been highlighted in this Screen of The Week article.
2 Top Ranked Stocks with Sky High Earnings Growth Forecasts
by Ethan Feller
Earnings growth is a leading indicator of a company's financial health and its potential for future stock price appreciation
Pick These 4 Solid Net Profit Margin Stocks for Solid Returns
by Anirudha Bhagat
Here we present four top-ranked stocks, ARCO, KRT, ANDE and OPCH, with solid net profit margins that can contribute toward making a strong portfolio.
Top Medical Stocks to Buy Amid Market Volatility
by Shaun Pruitt
While there is no guarantee that medical stocks will offer a hedge against market volatility, healthcare is essential even during economic uncertainty.
Best Growth Stocks to Buy for September 27th
by Zacks Equity Research
AMWD, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 27, 2023.
Best Growth Stocks to Buy for September 19th
by Zacks Equity Research
JOB, OPCH and SPLK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 19, 2023.
Recent Price Trend in Option Care (OPCH) is Your Friend, Here's Why
by Zacks Equity Research
Option Care (OPCH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Philips (PHG) Expands Mobile C-arm Portfolio With Zenition 30
by Zacks Equity Research
Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.
Best Growth Stocks to Buy for September 15th
by Zacks Equity Research
FOUR, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15, 2023.